Skip to main content
. 2019 Oct 21;5:145. doi: 10.1186/s40792-019-0707-5

Table 1.

Time course of serum magnesium level, ECG, level of dose reduction of chemotherapy, and supplementation of magnesium

Total number of administrations Mg sulfate supplementation Dose reduction Abnormality on ECG Serum Mg CTCAE grade
12 20 mEq None No 0.9 mg/dL 2
13 20 mEq 1st level No 1.0 mg/dL 2
14 20 mEq 1st level No 0.9 mg/dL 2
15 40 mEq 2nd level No 0.9 mg/dL 2
16 40 mEq 2nd level No 0.9 mg/dL 2
17 40 mEq 2nd level No 0.9 mg/dL 2

Mg magnesium, irinotecan, ECG electrocardiogram, CTCAE Common Terminology Criteria for Adverse Events